{
    "nct_id": "NCT03065244",
    "official_title": "KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)",
    "inclusion_criteria": "* Eligible subjects will be as follows:\n\n  1. 4 weeks to 17 years of age,\n  2. fulfill the American Heart Association case definition for complete or incomplete KD,\n  3. have had fever (T ≥38°C) for 3 to 10 days prior to initial IVIG treatment,\n  4. have fever (T ≥38°C orally or rectally) between 36 hours and 7 days after end of the first IVIG infusion without other likely cause\nHealthy volunteers allowed\nMust have maximum age of 17 Years",
    "exclusion_criteria": "1. Patient treated with infliximab or steroids for present illness (pts who received oral steroids as outpatients prior to KD diagnosis but who otherwise qualify for the study will not be excluded)\n2. Known prior infection with tuberculosis, coccidiomycosis, or histoplasmosis.",
    "miscellaneous_criteria": ""
}